190 related articles for article (PubMed ID: 36370412)
1. Plasmalogens and platelet-activating factor roles in chronic inflammatory diseases.
Tremblay MÈ; Almsherqi ZA; Deng Y
Biofactors; 2022 Nov; 48(6):1203-1216. PubMed ID: 36370412
[TBL] [Abstract][Full Text] [Related]
2. Plasmalogens and Chronic Inflammatory Diseases.
Bozelli JC; Azher S; Epand RM
Front Physiol; 2021; 12():730829. PubMed ID: 34744771
[TBL] [Abstract][Full Text] [Related]
3. Influence of platelet-activating factor, lyso-platelet-activating factor and edelfosine on Langmuir monolayers imitating plasma membranes of cell lines differing in susceptibility to anti-cancer treatment: the effect of plasmalogen level.
Flasiński M; Hąc-Wydro K; Wydro P; Dynarowicz-Łątka P
J R Soc Interface; 2014 Jun; 11(95):20131103. PubMed ID: 24694892
[TBL] [Abstract][Full Text] [Related]
4. Plasmalogenic Lipid Analogs as Platelet-Activating Factor Antagonists: A Potential Novel Class of Anti-inflammatory Compounds.
Rong P; Wang JL; Angelova A; Almsherqi ZA; Deng Y
Front Cell Dev Biol; 2022; 10():859421. PubMed ID: 35493091
[TBL] [Abstract][Full Text] [Related]
5. Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.
Dorninger F; Forss-Petter S; Wimmer I; Berger J
Neurobiol Dis; 2020 Nov; 145():105061. PubMed ID: 32861763
[TBL] [Abstract][Full Text] [Related]
6. Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis.
Lessig J; Fuchs B
Curr Med Chem; 2009; 16(16):2021-41. PubMed ID: 19519379
[TBL] [Abstract][Full Text] [Related]
7. A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acyl analogs of platelet-activating factor (PAF) with PAF as the acetate donor in HL-60 cells.
Lee TC; Uemura Y; Snyder F
J Biol Chem; 1992 Oct; 267(28):19992-20001. PubMed ID: 1400315
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of platelet activating factor and related ether lipids: enzymatic pathways, subcellular sites, regulation, and membrane processing.
Snyder F
Prog Clin Biol Res; 1988; 282():57-72. PubMed ID: 3071807
[TBL] [Abstract][Full Text] [Related]
9. Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer.
Messias MCF; Mecatti GC; Priolli DG; de Oliveira Carvalho P
Lipids Health Dis; 2018 Mar; 17(1):41. PubMed ID: 29514688
[TBL] [Abstract][Full Text] [Related]
10. Metabolic conversion of platelet-activating factor into ethanolamine plasmalogen in an amnion-derived cell line.
Frenkel RA; Johnston JM
J Biol Chem; 1992 Sep; 267(27):19186-91. PubMed ID: 1527040
[TBL] [Abstract][Full Text] [Related]
11. [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators].
Kulikov VI; Muzia GI
Biokhimiia; 1992 Jun; 57(6):803-16. PubMed ID: 1420585
[TBL] [Abstract][Full Text] [Related]
12. Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice.
Brites P; Ferreira AS; da Silva TF; Sousa VF; Malheiro AR; Duran M; Waterham HR; Baes M; Wanders RJ
PLoS One; 2011; 6(12):e28539. PubMed ID: 22163031
[TBL] [Abstract][Full Text] [Related]
13. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
14. Human and great ape red blood cells differ in plasmalogen levels and composition.
Moser AB; Steinberg SJ; Watkins PA; Moser HW; Ramaswamy K; Siegmund KD; Lee DR; Ely JJ; Ryder OA; Hacia JG
Lipids Health Dis; 2011 Jun; 10():101. PubMed ID: 21679470
[TBL] [Abstract][Full Text] [Related]
15. Orphan enzymes in ether lipid metabolism.
Watschinger K; Werner ER
Biochimie; 2013 Jan; 95(1):59-65. PubMed ID: 22771767
[TBL] [Abstract][Full Text] [Related]
16. Ether lipid synthesis and its deficiency in peroxisomal disorders.
van den Bosch H; Schrakamp G; Hardeman D; Zomer AW; Wanders RJ; Schutgens RB
Biochimie; 1993; 75(3-4):183-9. PubMed ID: 8507680
[TBL] [Abstract][Full Text] [Related]
17. Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.
Dorninger F; Brodde A; Braverman NE; Moser AB; Just WW; Forss-Petter S; Brügger B; Berger J
Biochim Biophys Acta; 2015 Feb; 1851(2):117-28. PubMed ID: 25463479
[TBL] [Abstract][Full Text] [Related]
18. The biophysical properties of plasmalogens originating from their unique molecular architecture.
Koivuniemi A
FEBS Lett; 2017 Sep; 591(18):2700-2713. PubMed ID: 28710769
[TBL] [Abstract][Full Text] [Related]
19. Polyunsaturated fatty acid incorporation into plasmalogens in plasma membrane of glioma cells is preceded temporally by acylation in microsomes.
Thomas SE; Morris SJ; Xu Z; Byers DM; Palmer FB; Spence MW; Cook HW
Biochim Biophys Acta; 1992 Jun; 1126(2):125-34. PubMed ID: 1627614
[TBL] [Abstract][Full Text] [Related]
20. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
